The association between atorvastatin use and prothrombin time, apolipoprotein A-I levels, and apolipoprotein B levels in patients with type 2 diabetes mellitus and no history of atherosclerotic cardiovascular diseases: a cross-sectional study

BACKGROUND AND OBJECTIVES: Recent observational studies have demonstrated an association between apolipoproteins and vitamin K-dependent coagulation factors. Further research investigating this association is required. This study aimed to assess the association between atorvastatin use and prothrombin time (PT), apolipoprotein A-I (ApoA-I) levels, and apolipoprotein B (ApoB) levels in type 2 diabetes mellitus (T2DM) patients without established atherosclerotic cardiovascular disease and to investigate the association between PT and these apolipoproteins. METHODS AND RESULTS: = 0.015). No significant association was observed between PT and ApoA-I. CONCLUSION: The inverse association between PT and ApoB may suggest a potential link between the reduction in ApoB levels, through atorvastatin use, and the modulation of coagulation pathways relevant to venous thrombosis, although this requires confirmation in future prospective studies.